ARCHIVES

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

This article is from The Cancer Letter archive.

Vol. 24 No. 25 | June 26, 1998

Download PDF Visit The Full Archive

Related Articles

Zerhouni Starts Work As NIH Director

May 24, 2002

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

14th Cancer Congress Big Success; CICA Satellite Established; US, USSR Renew Cancer Agreement

September 12, 1986

Rauscher “Identifies” Four More Comprehensive Centers

June 21, 1974

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says

November 29, 1996